nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—Nitrazepam—Clonazepam—epilepsy syndrome	0.114	0.54	CrCrCtD
Dantrolene—Nitrazepam—Diazepam—epilepsy syndrome	0.0971	0.46	CrCrCtD
Dantrolene—multiple sclerosis—Diazepam—epilepsy syndrome	0.0905	0.213	CpDpCtD
Dantrolene—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0905	0.213	CpDpCtD
Dantrolene—multiple sclerosis—Pregabalin—epilepsy syndrome	0.077	0.181	CpDpCtD
Dantrolene—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0686	0.161	CpDpCtD
Dantrolene—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0548	0.129	CpDpCtD
Dantrolene—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0442	0.104	CpDpCtD
Dantrolene—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0147	0.0879	CbGbCtD
Dantrolene—CYP3A4—Felbamate—epilepsy syndrome	0.0137	0.0817	CbGbCtD
Dantrolene—CYP3A4—Trimethadione—epilepsy syndrome	0.0137	0.0817	CbGbCtD
Dantrolene—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0128	0.0768	CbGbCtD
Dantrolene—CYP3A4—Clonazepam—epilepsy syndrome	0.0116	0.0694	CbGbCtD
Dantrolene—CYP3A4—Clobazam—epilepsy syndrome	0.0111	0.0666	CbGbCtD
Dantrolene—CYP3A4—Rufinamide—epilepsy syndrome	0.00947	0.0566	CbGbCtD
Dantrolene—CYP3A4—Carbamazepine—epilepsy syndrome	0.00922	0.0552	CbGbCtD
Dantrolene—CYP3A4—Primidone—epilepsy syndrome	0.00861	0.0515	CbGbCtD
Dantrolene—CYP3A4—Phenytoin—epilepsy syndrome	0.00827	0.0495	CbGbCtD
Dantrolene—CYP3A4—Propofol—epilepsy syndrome	0.00772	0.0462	CbGbCtD
Dantrolene—CYP3A4—Acetazolamide—epilepsy syndrome	0.00737	0.0441	CbGbCtD
Dantrolene—CYP3A4—Phenobarbital—epilepsy syndrome	0.00737	0.0441	CbGbCtD
Dantrolene—CYP3A4—Midazolam—epilepsy syndrome	0.00727	0.0435	CbGbCtD
Dantrolene—CYP3A4—Diazepam—epilepsy syndrome	0.00699	0.0418	CbGbCtD
Dantrolene—CYP3A4—Zonisamide—epilepsy syndrome	0.00682	0.0408	CbGbCtD
Dantrolene—CYP3A4—Valproic Acid—epilepsy syndrome	0.00551	0.033	CbGbCtD
Dantrolene—CYP3A4—Topiramate—epilepsy syndrome	0.00497	0.0297	CbGbCtD
Dantrolene—RYR3—forebrain—epilepsy syndrome	0.00238	0.106	CbGeAlD
Dantrolene—RYR3—telencephalon—epilepsy syndrome	0.00219	0.0971	CbGeAlD
Dantrolene—RYR3—medulla oblongata—epilepsy syndrome	0.00172	0.0763	CbGeAlD
Dantrolene—RYR3—midbrain—epilepsy syndrome	0.00157	0.0697	CbGeAlD
Dantrolene—RYR3—spinal cord—epilepsy syndrome	0.00153	0.068	CbGeAlD
Dantrolene—RYR3—head—epilepsy syndrome	0.00136	0.0604	CbGeAlD
Dantrolene—RYR3—nervous system—epilepsy syndrome	0.00129	0.0573	CbGeAlD
Dantrolene—RYR3—central nervous system—epilepsy syndrome	0.00124	0.0552	CbGeAlD
Dantrolene—RYR1—medulla oblongata—epilepsy syndrome	0.00123	0.0547	CbGeAlD
Dantrolene—RYR3—cerebellum—epilepsy syndrome	0.00121	0.0539	CbGeAlD
Dantrolene—RYR1—midbrain—epilepsy syndrome	0.00113	0.05	CbGeAlD
Dantrolene—RYR3—brain—epilepsy syndrome	0.000986	0.0438	CbGeAlD
Dantrolene—RYR1—head—epilepsy syndrome	0.000976	0.0434	CbGeAlD
Dantrolene—RYR1—nervous system—epilepsy syndrome	0.000926	0.0411	CbGeAlD
Dantrolene—RYR1—central nervous system—epilepsy syndrome	0.000891	0.0396	CbGeAlD
Dantrolene—RYR1—cerebellum—epilepsy syndrome	0.000871	0.0387	CbGeAlD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—SLC8A3—epilepsy syndrome	0.000746	0.013	CbGpPWpGaD
Dantrolene—RYR1—brain—epilepsy syndrome	0.000707	0.0314	CbGeAlD
Dantrolene—RYR3—Ion channel transport—GABRG2—epilepsy syndrome	0.000698	0.0122	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJB6—epilepsy syndrome	0.000665	0.0116	CbGpPWpGaD
Dantrolene—RYR3—Stimuli-sensing channels—TRPV1—epilepsy syndrome	0.00066	0.0115	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—GRIN2A—epilepsy syndrome	0.000634	0.0111	CbGpPWpGaD
Dantrolene—Nitrofurantoin—ABCG2—epilepsy syndrome	0.000592	0.268	CrCbGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—KCNB1—epilepsy syndrome	0.000576	0.0101	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—ATP2A2—epilepsy syndrome	0.000565	0.00986	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CACNA1A—epilepsy syndrome	0.000565	0.00986	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—SLC8A3—epilepsy syndrome	0.00055	0.00959	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—GABRA5—epilepsy syndrome	0.000529	0.00922	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CACNA1D—epilepsy syndrome	0.000522	0.0091	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—GABRG2—epilepsy syndrome	0.000514	0.00897	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ARHGEF9—epilepsy syndrome	0.000507	0.00884	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—GABRA1—epilepsy syndrome	0.000507	0.00884	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—GABRB3—epilepsy syndrome	0.000507	0.00884	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJB6—epilepsy syndrome	0.00049	0.00855	CbGpPWpGaD
Dantrolene—RYR1—Stimuli-sensing channels—TRPV1—epilepsy syndrome	0.000487	0.00849	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GNAO1—epilepsy syndrome	0.000481	0.00838	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CHRM1—epilepsy syndrome	0.000461	0.00804	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—GRIN2B—epilepsy syndrome	0.000459	0.008	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—PLCB1—epilepsy syndrome	0.000454	0.00791	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—NOS1—epilepsy syndrome	0.000452	0.00788	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—GABRB2—epilepsy syndrome	0.00045	0.00784	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—SLC8A1—epilepsy syndrome	0.000444	0.00774	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—TRPV1—epilepsy syndrome	0.000431	0.00752	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—SLC8A1—epilepsy syndrome	0.00043	0.0075	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CHRM3—epilepsy syndrome	0.000428	0.00747	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CACNA1A—epilepsy syndrome	0.000417	0.00727	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—ADAM10—epilepsy syndrome	0.000413	0.00721	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CHRM2—epilepsy syndrome	0.000403	0.00703	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—GABRA5—epilepsy syndrome	0.00039	0.0068	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CACNA1D—epilepsy syndrome	0.000385	0.00671	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000377	0.00657	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000377	0.00657	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ARHGEF9—epilepsy syndrome	0.000374	0.00652	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—GABRA1—epilepsy syndrome	0.000374	0.00652	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—GABRB3—epilepsy syndrome	0.000374	0.00652	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GNAO1—epilepsy syndrome	0.000354	0.00618	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ATP2A2—epilepsy syndrome	0.00034	0.00594	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CHRM1—epilepsy syndrome	0.00034	0.00593	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000336	0.00586	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000336	0.00586	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000336	0.00586	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—GABRB2—epilepsy syndrome	0.000331	0.00578	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ATP2A2—epilepsy syndrome	0.00033	0.00575	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—SLC8A1—epilepsy syndrome	0.000327	0.0057	CbGpPWpGaD
Dantrolene—Nitrazepam—GABRD—epilepsy syndrome	0.000327	0.148	CrCbGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ACTB—epilepsy syndrome	0.000326	0.00568	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ATP2A2—epilepsy syndrome	0.000318	0.00555	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CRH—epilepsy syndrome	0.000318	0.00555	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—OXT—epilepsy syndrome	0.000318	0.00555	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—TRPV1—epilepsy syndrome	0.000318	0.00554	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—SLC8A1—epilepsy syndrome	0.000317	0.00553	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CHRM3—epilepsy syndrome	0.000316	0.00551	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000307	0.00536	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CHRM2—epilepsy syndrome	0.000297	0.00518	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—APOE—epilepsy syndrome	0.000289	0.00504	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000278	0.00485	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000278	0.00485	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000268	0.00468	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS1—epilepsy syndrome	0.000264	0.0046	CbGpPWpGaD
Dantrolene—Nitrazepam—SCN1A—epilepsy syndrome	0.000256	0.116	CrCbGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000254	0.00444	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000254	0.00444	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000254	0.00444	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ATP2A2—epilepsy syndrome	0.000251	0.00438	CbGpPWpGaD
Dantrolene—Nitrazepam—GABRG2—epilepsy syndrome	0.000248	0.112	CrCbGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000248	0.00432	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000248	0.00432	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000248	0.00432	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATP2A2—epilepsy syndrome	0.000243	0.00424	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP8—epilepsy syndrome	0.000243	0.00424	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000243	0.00424	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000243	0.00424	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ACTB—epilepsy syndrome	0.00024	0.00419	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ATP2A2—epilepsy syndrome	0.000235	0.00409	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—OXT—epilepsy syndrome	0.000235	0.00409	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CRH—epilepsy syndrome	0.000235	0.00409	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000226	0.00395	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000218	0.0038	CbGpPWpGaD
Dantrolene—Nitrazepam—GABRA5—epilepsy syndrome	0.000199	0.0902	CrCbGaD
Dantrolene—Nitrazepam—GABRB3—epilepsy syndrome	0.000199	0.0902	CrCbGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—YWHAZ—epilepsy syndrome	0.000199	0.00347	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000198	0.00345	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000198	0.00345	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS1—epilepsy syndrome	0.000194	0.00339	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000193	0.00336	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000193	0.00336	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—YWHAZ—epilepsy syndrome	0.000193	0.00336	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000188	0.00327	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000188	0.00327	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000188	0.00327	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—IL1B—epilepsy syndrome	0.000184	0.00322	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000184	0.00321	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP3—epilepsy syndrome	0.000184	0.00321	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000179	0.00312	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000179	0.00312	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000176	0.00308	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000176	0.00308	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000176	0.00308	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000176	0.00308	CbGpPWpGaD
Dantrolene—Nitrazepam—GABRB2—epilepsy syndrome	0.000175	0.079	CrCbGaD
Dantrolene—Nitrazepam—GABRA1—epilepsy syndrome	0.000171	0.0775	CrCbGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCB—epilepsy syndrome	0.000164	0.00286	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000164	0.00286	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000162	0.00282	CbGpPWpGaD
Dantrolene—CYP3A4—nervous system—epilepsy syndrome	0.000161	0.00715	CbGeAlD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCB—epilepsy syndrome	0.000159	0.00277	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000156	0.00273	CbGpPWpGaD
Dantrolene—CYP3A4—central nervous system—epilepsy syndrome	0.000155	0.00688	CbGeAlD
Dantrolene—RYR3—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000154	0.00269	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.00015	0.00262	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—YWHAZ—epilepsy syndrome	0.000147	0.00256	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000146	0.00255	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—FOS—epilepsy syndrome	0.000145	0.00253	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000144	0.00252	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000142	0.00248	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000142	0.00248	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—YWHAZ—epilepsy syndrome	0.000142	0.00248	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000139	0.00243	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000139	0.00243	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.000139	0.00243	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000136	0.00237	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	0.000135	0.00235	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—epilepsy syndrome	0.000134	0.00233	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000134	0.00233	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.00013	0.00227	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.00013	0.00227	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.00013	0.00227	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.00013	0.00227	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000124	0.00217	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCB—epilepsy syndrome	0.000121	0.00211	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000121	0.00211	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000119	0.00208	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000118	0.00206	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCB—epilepsy syndrome	0.000117	0.00205	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000116	0.00202	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000115	0.00201	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000114	0.00198	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000114	0.00198	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000111	0.00193	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000111	0.00193	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—epilepsy syndrome	0.000108	0.00188	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—FOS—epilepsy syndrome	0.000107	0.00187	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000106	0.00186	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—JUN—epilepsy syndrome	0.000104	0.00182	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000103	0.00179	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000103	0.00179	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	9.86e-05	0.00172	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	9.8e-05	0.00171	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.42e-05	0.00164	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	9.29e-05	0.00162	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	9.16e-05	0.0016	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.99e-05	0.00157	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	8.67e-05	0.00151	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.38e-05	0.00146	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	8.34e-05	0.00145	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.17e-05	0.00142	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—epilepsy syndrome	7.93e-05	0.00138	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	7.77e-05	0.00136	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—JUN—epilepsy syndrome	7.68e-05	0.00134	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	7.48e-05	0.0013	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.39e-05	0.00129	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.33e-05	0.00128	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	7.18e-05	0.00125	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.09e-05	0.00124	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.94e-05	0.00121	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	6.84e-05	0.00119	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.62e-05	0.00116	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	6.32e-05	0.0011	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	6.31e-05	0.0011	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	6.29e-05	0.0011	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	5.95e-05	0.00104	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.45e-05	0.000951	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.4e-05	0.000942	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.23e-05	0.000912	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	4.63e-05	0.000808	CbGpPWpGaD
Dantrolene—Anaemia—Pregabalin—epilepsy syndrome	4.48e-05	0.000393	CcSEcCtD
Dantrolene—Dermatitis—Levetiracetam—epilepsy syndrome	4.48e-05	0.000393	CcSEcCtD
Dantrolene—Asthenia—Zonisamide—epilepsy syndrome	4.47e-05	0.000393	CcSEcCtD
Dantrolene—Dry mouth—Valproic Acid—epilepsy syndrome	4.46e-05	0.000392	CcSEcCtD
Dantrolene—Headache—Levetiracetam—epilepsy syndrome	4.45e-05	0.000391	CcSEcCtD
Dantrolene—Erythema—Gabapentin—epilepsy syndrome	4.44e-05	0.00039	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.44e-05	0.000774	CbGpPWpGaD
Dantrolene—Hypersensitivity—Clonazepam—epilepsy syndrome	4.43e-05	0.000389	CcSEcCtD
Dantrolene—Dizziness—Vigabatrin—epilepsy syndrome	4.42e-05	0.000388	CcSEcCtD
Dantrolene—Confusional state—Valproic Acid—epilepsy syndrome	4.41e-05	0.000387	CcSEcCtD
Dantrolene—Pruritus—Zonisamide—epilepsy syndrome	4.41e-05	0.000387	CcSEcCtD
Dantrolene—Hypersensitivity—Phenytoin—epilepsy syndrome	4.4e-05	0.000386	CcSEcCtD
Dantrolene—Anaphylactic shock—Valproic Acid—epilepsy syndrome	4.38e-05	0.000384	CcSEcCtD
Dantrolene—Urticaria—Lamotrigine—epilepsy syndrome	4.37e-05	0.000384	CcSEcCtD
Dantrolene—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.37e-05	0.000384	CcSEcCtD
Dantrolene—Malaise—Pregabalin—epilepsy syndrome	4.37e-05	0.000384	CcSEcCtD
Dantrolene—Nausea—Propofol—epilepsy syndrome	4.37e-05	0.000384	CcSEcCtD
Dantrolene—Tension—Gabapentin—epilepsy syndrome	4.36e-05	0.000383	CcSEcCtD
Dantrolene—Vomiting—Fosphenytoin—epilepsy syndrome	4.36e-05	0.000383	CcSEcCtD
Dantrolene—Diarrhoea—Felbamate—epilepsy syndrome	4.36e-05	0.000383	CcSEcCtD
Dantrolene—Body temperature increased—Lamotrigine—epilepsy syndrome	4.35e-05	0.000382	CcSEcCtD
Dantrolene—Abdominal pain—Lamotrigine—epilepsy syndrome	4.35e-05	0.000382	CcSEcCtD
Dantrolene—Dysgeusia—Gabapentin—epilepsy syndrome	4.35e-05	0.000382	CcSEcCtD
Dantrolene—Dizziness—Diazepam—epilepsy syndrome	4.35e-05	0.000382	CcSEcCtD
Dantrolene—Leukopenia—Pregabalin—epilepsy syndrome	4.34e-05	0.000381	CcSEcCtD
Dantrolene—Rash—Fosphenytoin—epilepsy syndrome	4.32e-05	0.00038	CcSEcCtD
Dantrolene—Dermatitis—Fosphenytoin—epilepsy syndrome	4.32e-05	0.000379	CcSEcCtD
Dantrolene—Haemoglobin—Topiramate—epilepsy syndrome	4.32e-05	0.000379	CcSEcCtD
Dantrolene—Nervousness—Gabapentin—epilepsy syndrome	4.32e-05	0.000379	CcSEcCtD
Dantrolene—Asthenia—Clonazepam—epilepsy syndrome	4.31e-05	0.000378	CcSEcCtD
Dantrolene—Back pain—Gabapentin—epilepsy syndrome	4.3e-05	0.000377	CcSEcCtD
Dantrolene—Headache—Fosphenytoin—epilepsy syndrome	4.3e-05	0.000377	CcSEcCtD
Dantrolene—Hepatitis—Topiramate—epilepsy syndrome	4.3e-05	0.000377	CcSEcCtD
Dantrolene—Haemorrhage—Topiramate—epilepsy syndrome	4.3e-05	0.000377	CcSEcCtD
Dantrolene—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.28e-05	0.000376	CcSEcCtD
Dantrolene—Asthenia—Phenytoin—epilepsy syndrome	4.28e-05	0.000376	CcSEcCtD
Dantrolene—Nausea—Midazolam—epilepsy syndrome	4.27e-05	0.000375	CcSEcCtD
Dantrolene—Tachycardia—Valproic Acid—epilepsy syndrome	4.27e-05	0.000375	CcSEcCtD
Dantrolene—Diarrhoea—Zonisamide—epilepsy syndrome	4.27e-05	0.000375	CcSEcCtD
Dantrolene—Asthenia—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000374	CcSEcCtD
Dantrolene—Nitrazepam—ABCB1—epilepsy syndrome	4.26e-05	0.0193	CrCbGaD
Dantrolene—Pruritus—Clonazepam—epilepsy syndrome	4.25e-05	0.000373	CcSEcCtD
Dantrolene—Vomiting—Vigabatrin—epilepsy syndrome	4.25e-05	0.000373	CcSEcCtD
Dantrolene—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.23e-05	0.000371	CcSEcCtD
Dantrolene—Pruritus—Phenytoin—epilepsy syndrome	4.22e-05	0.000371	CcSEcCtD
Dantrolene—Nausea—Levetiracetam—epilepsy syndrome	4.22e-05	0.000371	CcSEcCtD
Dantrolene—Rash—Vigabatrin—epilepsy syndrome	4.21e-05	0.00037	CcSEcCtD
Dantrolene—Dizziness—Felbamate—epilepsy syndrome	4.21e-05	0.00037	CcSEcCtD
Dantrolene—Dermatitis—Vigabatrin—epilepsy syndrome	4.21e-05	0.00037	CcSEcCtD
Dantrolene—Pruritus—Oxcarbazepine—epilepsy syndrome	4.2e-05	0.000369	CcSEcCtD
Dantrolene—Convulsion—Pregabalin—epilepsy syndrome	4.2e-05	0.000369	CcSEcCtD
Dantrolene—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.2e-05	0.000369	CcSEcCtD
Dantrolene—Vision blurred—Gabapentin—epilepsy syndrome	4.19e-05	0.000368	CcSEcCtD
Dantrolene—Headache—Vigabatrin—epilepsy syndrome	4.19e-05	0.000368	CcSEcCtD
Dantrolene—Hypertension—Pregabalin—epilepsy syndrome	4.18e-05	0.000367	CcSEcCtD
Dantrolene—Vomiting—Diazepam—epilepsy syndrome	4.18e-05	0.000367	CcSEcCtD
Dantrolene—Anorexia—Valproic Acid—epilepsy syndrome	4.17e-05	0.000366	CcSEcCtD
Dantrolene—Rash—Diazepam—epilepsy syndrome	4.15e-05	0.000364	CcSEcCtD
Dantrolene—Dermatitis—Diazepam—epilepsy syndrome	4.15e-05	0.000364	CcSEcCtD
Dantrolene—Visual impairment—Topiramate—epilepsy syndrome	4.14e-05	0.000363	CcSEcCtD
Dantrolene—Myalgia—Pregabalin—epilepsy syndrome	4.13e-05	0.000362	CcSEcCtD
Dantrolene—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.12e-05	0.000362	CcSEcCtD
Dantrolene—Dizziness—Zonisamide—epilepsy syndrome	4.12e-05	0.000362	CcSEcCtD
Dantrolene—Headache—Diazepam—epilepsy syndrome	4.12e-05	0.000362	CcSEcCtD
Dantrolene—Diarrhoea—Clonazepam—epilepsy syndrome	4.11e-05	0.000361	CcSEcCtD
Dantrolene—Anaemia—Gabapentin—epilepsy syndrome	4.11e-05	0.000361	CcSEcCtD
Dantrolene—Asthenia—Carbamazepine—epilepsy syndrome	4.09e-05	0.000359	CcSEcCtD
Dantrolene—Diarrhoea—Phenytoin—epilepsy syndrome	4.08e-05	0.000359	CcSEcCtD
Dantrolene—Discomfort—Pregabalin—epilepsy syndrome	4.08e-05	0.000358	CcSEcCtD
Dantrolene—Nausea—Fosphenytoin—epilepsy syndrome	4.07e-05	0.000358	CcSEcCtD
Dantrolene—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.06e-05	0.000357	CcSEcCtD
Dantrolene—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.06e-05	0.000356	CcSEcCtD
Dantrolene—Vomiting—Felbamate—epilepsy syndrome	4.05e-05	0.000356	CcSEcCtD
Dantrolene—Dry mouth—Pregabalin—epilepsy syndrome	4.04e-05	0.000354	CcSEcCtD
Dantrolene—Pruritus—Carbamazepine—epilepsy syndrome	4.03e-05	0.000354	CcSEcCtD
Dantrolene—Rash—Felbamate—epilepsy syndrome	4.02e-05	0.000353	CcSEcCtD
Dantrolene—Dermatitis—Felbamate—epilepsy syndrome	4.01e-05	0.000352	CcSEcCtD
Dantrolene—Malaise—Gabapentin—epilepsy syndrome	4.01e-05	0.000352	CcSEcCtD
Dantrolene—Headache—Felbamate—epilepsy syndrome	3.99e-05	0.00035	CcSEcCtD
Dantrolene—Confusional state—Pregabalin—epilepsy syndrome	3.99e-05	0.00035	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.99e-05	0.00035	CcSEcCtD
Dantrolene—Flushing—Topiramate—epilepsy syndrome	3.99e-05	0.00035	CcSEcCtD
Dantrolene—Leukopenia—Gabapentin—epilepsy syndrome	3.98e-05	0.000349	CcSEcCtD
Dantrolene—Dizziness—Clonazepam—epilepsy syndrome	3.97e-05	0.000349	CcSEcCtD
Dantrolene—Nausea—Vigabatrin—epilepsy syndrome	3.97e-05	0.000349	CcSEcCtD
Dantrolene—Vomiting—Zonisamide—epilepsy syndrome	3.96e-05	0.000348	CcSEcCtD
Dantrolene—Insomnia—Valproic Acid—epilepsy syndrome	3.96e-05	0.000347	CcSEcCtD
Dantrolene—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.96e-05	0.000347	CcSEcCtD
Dantrolene—Asthenia—Lamotrigine—epilepsy syndrome	3.95e-05	0.000347	CcSEcCtD
Dantrolene—Dizziness—Phenytoin—epilepsy syndrome	3.95e-05	0.000347	CcSEcCtD
Dantrolene—Rash—Zonisamide—epilepsy syndrome	3.93e-05	0.000345	CcSEcCtD
Dantrolene—Dermatitis—Zonisamide—epilepsy syndrome	3.93e-05	0.000345	CcSEcCtD
Dantrolene—Dizziness—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.000345	CcSEcCtD
Dantrolene—Nausea—Diazepam—epilepsy syndrome	3.91e-05	0.000343	CcSEcCtD
Dantrolene—Headache—Zonisamide—epilepsy syndrome	3.91e-05	0.000343	CcSEcCtD
Dantrolene—Diarrhoea—Carbamazepine—epilepsy syndrome	3.9e-05	0.000342	CcSEcCtD
Dantrolene—Pruritus—Lamotrigine—epilepsy syndrome	3.9e-05	0.000342	CcSEcCtD
Dantrolene—Somnolence—Valproic Acid—epilepsy syndrome	3.89e-05	0.000342	CcSEcCtD
Dantrolene—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.87e-05	0.00034	CcSEcCtD
Dantrolene—Tachycardia—Pregabalin—epilepsy syndrome	3.86e-05	0.000339	CcSEcCtD
Dantrolene—Chills—Topiramate—epilepsy syndrome	3.85e-05	0.000338	CcSEcCtD
Dantrolene—Dyspepsia—Valproic Acid—epilepsy syndrome	3.85e-05	0.000338	CcSEcCtD
Dantrolene—Convulsion—Gabapentin—epilepsy syndrome	3.85e-05	0.000338	CcSEcCtD
Dantrolene—Hypertension—Gabapentin—epilepsy syndrome	3.84e-05	0.000337	CcSEcCtD
Dantrolene—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.82e-05	0.000336	CcSEcCtD
Dantrolene—Vomiting—Clonazepam—epilepsy syndrome	3.82e-05	0.000335	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	3.81e-05	0.000665	CbGpPWpGaD
Dantrolene—Decreased appetite—Valproic Acid—epilepsy syndrome	3.8e-05	0.000334	CcSEcCtD
Dantrolene—Vomiting—Phenytoin—epilepsy syndrome	3.79e-05	0.000333	CcSEcCtD
Dantrolene—Rash—Clonazepam—epilepsy syndrome	3.79e-05	0.000333	CcSEcCtD
Dantrolene—Dermatitis—Clonazepam—epilepsy syndrome	3.79e-05	0.000332	CcSEcCtD
Dantrolene—Myalgia—Gabapentin—epilepsy syndrome	3.78e-05	0.000332	CcSEcCtD
Dantrolene—Nausea—Felbamate—epilepsy syndrome	3.78e-05	0.000332	CcSEcCtD
Dantrolene—Vomiting—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.000331	CcSEcCtD
Dantrolene—Fatigue—Valproic Acid—epilepsy syndrome	3.77e-05	0.000331	CcSEcCtD
Dantrolene—Anorexia—Pregabalin—epilepsy syndrome	3.77e-05	0.000331	CcSEcCtD
Dantrolene—Dizziness—Carbamazepine—epilepsy syndrome	3.77e-05	0.000331	CcSEcCtD
Dantrolene—Diarrhoea—Lamotrigine—epilepsy syndrome	3.77e-05	0.000331	CcSEcCtD
Dantrolene—Headache—Clonazepam—epilepsy syndrome	3.76e-05	0.00033	CcSEcCtD
Dantrolene—Rash—Phenytoin—epilepsy syndrome	3.76e-05	0.00033	CcSEcCtD
Dantrolene—Dermatitis—Phenytoin—epilepsy syndrome	3.76e-05	0.00033	CcSEcCtD
Dantrolene—Rash—Oxcarbazepine—epilepsy syndrome	3.74e-05	0.000329	CcSEcCtD
Dantrolene—Constipation—Valproic Acid—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Dantrolene—Pain—Valproic Acid—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Dantrolene—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Dantrolene—Headache—Phenytoin—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Dantrolene—Erythema—Topiramate—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Dantrolene—Discomfort—Gabapentin—epilepsy syndrome	3.74e-05	0.000328	CcSEcCtD
Dantrolene—Headache—Oxcarbazepine—epilepsy syndrome	3.72e-05	0.000327	CcSEcCtD
Dantrolene—Nausea—Zonisamide—epilepsy syndrome	3.7e-05	0.000325	CcSEcCtD
Dantrolene—Dry mouth—Gabapentin—epilepsy syndrome	3.7e-05	0.000325	CcSEcCtD
Dantrolene—Tension—Topiramate—epilepsy syndrome	3.67e-05	0.000322	CcSEcCtD
Dantrolene—Dysgeusia—Topiramate—epilepsy syndrome	3.66e-05	0.000321	CcSEcCtD
Dantrolene—Confusional state—Gabapentin—epilepsy syndrome	3.66e-05	0.000321	CcSEcCtD
Dantrolene—Dizziness—Lamotrigine—epilepsy syndrome	3.64e-05	0.00032	CcSEcCtD
Dantrolene—Nervousness—Topiramate—epilepsy syndrome	3.63e-05	0.000319	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	3.63e-05	0.000633	CbGpPWpGaD
Dantrolene—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.63e-05	0.000318	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	3.62e-05	0.000632	CbGpPWpGaD
Dantrolene—Vomiting—Carbamazepine—epilepsy syndrome	3.62e-05	0.000318	CcSEcCtD
Dantrolene—Back pain—Topiramate—epilepsy syndrome	3.62e-05	0.000318	CcSEcCtD
Dantrolene—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.61e-05	0.000317	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.6e-05	0.000316	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	3.6e-05	0.000628	CbGpPWpGaD
Dantrolene—Rash—Carbamazepine—epilepsy syndrome	3.59e-05	0.000315	CcSEcCtD
Dantrolene—Dermatitis—Carbamazepine—epilepsy syndrome	3.59e-05	0.000315	CcSEcCtD
Dantrolene—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.58e-05	0.000314	CcSEcCtD
Dantrolene—Insomnia—Pregabalin—epilepsy syndrome	3.58e-05	0.000314	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	3.58e-05	0.000624	CbGpPWpGaD
Dantrolene—Nausea—Clonazepam—epilepsy syndrome	3.57e-05	0.000313	CcSEcCtD
Dantrolene—Headache—Carbamazepine—epilepsy syndrome	3.57e-05	0.000313	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	3.55e-05	0.00062	CbGpPWpGaD
Dantrolene—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.55e-05	0.000312	CcSEcCtD
Dantrolene—Nausea—Phenytoin—epilepsy syndrome	3.55e-05	0.000311	CcSEcCtD
Dantrolene—Tachycardia—Gabapentin—epilepsy syndrome	3.54e-05	0.000311	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	3.53e-05	0.000616	CbGpPWpGaD
Dantrolene—Nausea—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.00031	CcSEcCtD
Dantrolene—Vision blurred—Topiramate—epilepsy syndrome	3.52e-05	0.000309	CcSEcCtD
Dantrolene—Somnolence—Pregabalin—epilepsy syndrome	3.52e-05	0.000309	CcSEcCtD
Dantrolene—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.51e-05	0.000308	CcSEcCtD
Dantrolene—Vomiting—Lamotrigine—epilepsy syndrome	3.5e-05	0.000307	CcSEcCtD
Dantrolene—Urticaria—Valproic Acid—epilepsy syndrome	3.48e-05	0.000305	CcSEcCtD
Dantrolene—Rash—Lamotrigine—epilepsy syndrome	3.47e-05	0.000305	CcSEcCtD
Dantrolene—Ill-defined disorder—Topiramate—epilepsy syndrome	3.47e-05	0.000305	CcSEcCtD
Dantrolene—Dermatitis—Lamotrigine—epilepsy syndrome	3.47e-05	0.000305	CcSEcCtD
Dantrolene—Abdominal pain—Valproic Acid—epilepsy syndrome	3.46e-05	0.000304	CcSEcCtD
Dantrolene—Body temperature increased—Valproic Acid—epilepsy syndrome	3.46e-05	0.000304	CcSEcCtD
Dantrolene—Anorexia—Gabapentin—epilepsy syndrome	3.46e-05	0.000304	CcSEcCtD
Dantrolene—Anaemia—Topiramate—epilepsy syndrome	3.46e-05	0.000303	CcSEcCtD
Dantrolene—Headache—Lamotrigine—epilepsy syndrome	3.45e-05	0.000303	CcSEcCtD
Dantrolene—Decreased appetite—Pregabalin—epilepsy syndrome	3.44e-05	0.000302	CcSEcCtD
Dantrolene—Fatigue—Pregabalin—epilepsy syndrome	3.41e-05	0.000299	CcSEcCtD
Dantrolene—Nausea—Carbamazepine—epilepsy syndrome	3.38e-05	0.000297	CcSEcCtD
Dantrolene—Pain—Pregabalin—epilepsy syndrome	3.38e-05	0.000297	CcSEcCtD
Dantrolene—Constipation—Pregabalin—epilepsy syndrome	3.38e-05	0.000297	CcSEcCtD
Dantrolene—Malaise—Topiramate—epilepsy syndrome	3.37e-05	0.000296	CcSEcCtD
Dantrolene—Leukopenia—Topiramate—epilepsy syndrome	3.35e-05	0.000294	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.3e-05	0.00029	CcSEcCtD
Dantrolene—Insomnia—Gabapentin—epilepsy syndrome	3.28e-05	0.000288	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.27e-05	0.000571	CbGpPWpGaD
Dantrolene—Nausea—Lamotrigine—epilepsy syndrome	3.27e-05	0.000287	CcSEcCtD
Dantrolene—Feeling abnormal—Pregabalin—epilepsy syndrome	3.26e-05	0.000286	CcSEcCtD
Dantrolene—Convulsion—Topiramate—epilepsy syndrome	3.24e-05	0.000284	CcSEcCtD
Dantrolene—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.23e-05	0.000284	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.23e-05	0.000563	CbGpPWpGaD
Dantrolene—Hypertension—Topiramate—epilepsy syndrome	3.23e-05	0.000283	CcSEcCtD
Dantrolene—Somnolence—Gabapentin—epilepsy syndrome	3.22e-05	0.000283	CcSEcCtD
Dantrolene—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.22e-05	0.000283	CcSEcCtD
Dantrolene—Dyspepsia—Gabapentin—epilepsy syndrome	3.19e-05	0.00028	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.19e-05	0.000556	CbGpPWpGaD
Dantrolene—Myalgia—Topiramate—epilepsy syndrome	3.18e-05	0.000279	CcSEcCtD
Dantrolene—Decreased appetite—Gabapentin—epilepsy syndrome	3.15e-05	0.000277	CcSEcCtD
Dantrolene—Discomfort—Topiramate—epilepsy syndrome	3.15e-05	0.000276	CcSEcCtD
Dantrolene—Urticaria—Pregabalin—epilepsy syndrome	3.14e-05	0.000276	CcSEcCtD
Dantrolene—Asthenia—Valproic Acid—epilepsy syndrome	3.14e-05	0.000276	CcSEcCtD
Dantrolene—Fatigue—Gabapentin—epilepsy syndrome	3.13e-05	0.000275	CcSEcCtD
Dantrolene—Abdominal pain—Pregabalin—epilepsy syndrome	3.13e-05	0.000275	CcSEcCtD
Dantrolene—Body temperature increased—Pregabalin—epilepsy syndrome	3.13e-05	0.000275	CcSEcCtD
Dantrolene—Dry mouth—Topiramate—epilepsy syndrome	3.11e-05	0.000273	CcSEcCtD
Dantrolene—Pain—Gabapentin—epilepsy syndrome	3.1e-05	0.000272	CcSEcCtD
Dantrolene—Constipation—Gabapentin—epilepsy syndrome	3.1e-05	0.000272	CcSEcCtD
Dantrolene—Pruritus—Valproic Acid—epilepsy syndrome	3.1e-05	0.000272	CcSEcCtD
Dantrolene—Confusional state—Topiramate—epilepsy syndrome	3.08e-05	0.00027	CcSEcCtD
Dantrolene—Diarrhoea—Valproic Acid—epilepsy syndrome	2.99e-05	0.000263	CcSEcCtD
Dantrolene—Feeling abnormal—Gabapentin—epilepsy syndrome	2.99e-05	0.000262	CcSEcCtD
Dantrolene—Thrombocytopenia—Topiramate—epilepsy syndrome	2.99e-05	0.000262	CcSEcCtD
Dantrolene—Tachycardia—Topiramate—epilepsy syndrome	2.98e-05	0.000261	CcSEcCtD
Dantrolene—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.97e-05	0.00026	CcSEcCtD
Dantrolene—Hyperhidrosis—Topiramate—epilepsy syndrome	2.95e-05	0.000259	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	2.93e-05	0.000511	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	2.92e-05	0.000509	CbGpPWpGaD
Dantrolene—Hypersensitivity—Pregabalin—epilepsy syndrome	2.91e-05	0.000256	CcSEcCtD
Dantrolene—Anorexia—Topiramate—epilepsy syndrome	2.91e-05	0.000255	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	2.9e-05	0.000506	CbGpPWpGaD
Dantrolene—Dizziness—Valproic Acid—epilepsy syndrome	2.89e-05	0.000254	CcSEcCtD
Dantrolene—Urticaria—Gabapentin—epilepsy syndrome	2.88e-05	0.000253	CcSEcCtD
Dantrolene—Body temperature increased—Gabapentin—epilepsy syndrome	2.87e-05	0.000252	CcSEcCtD
Dantrolene—Abdominal pain—Gabapentin—epilepsy syndrome	2.87e-05	0.000252	CcSEcCtD
Dantrolene—Asthenia—Pregabalin—epilepsy syndrome	2.84e-05	0.000249	CcSEcCtD
Dantrolene—Pruritus—Pregabalin—epilepsy syndrome	2.8e-05	0.000246	CcSEcCtD
Dantrolene—Vomiting—Valproic Acid—epilepsy syndrome	2.78e-05	0.000244	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.78e-05	0.000244	CcSEcCtD
Dantrolene—Insomnia—Topiramate—epilepsy syndrome	2.76e-05	0.000242	CcSEcCtD
Dantrolene—Rash—Valproic Acid—epilepsy syndrome	2.76e-05	0.000242	CcSEcCtD
Dantrolene—Dermatitis—Valproic Acid—epilepsy syndrome	2.76e-05	0.000242	CcSEcCtD
Dantrolene—Headache—Valproic Acid—epilepsy syndrome	2.74e-05	0.000241	CcSEcCtD
Dantrolene—Somnolence—Topiramate—epilepsy syndrome	2.71e-05	0.000238	CcSEcCtD
Dantrolene—Diarrhoea—Pregabalin—epilepsy syndrome	2.71e-05	0.000238	CcSEcCtD
Dantrolene—Dyspepsia—Topiramate—epilepsy syndrome	2.69e-05	0.000236	CcSEcCtD
Dantrolene—Hypersensitivity—Gabapentin—epilepsy syndrome	2.67e-05	0.000235	CcSEcCtD
Dantrolene—Decreased appetite—Topiramate—epilepsy syndrome	2.65e-05	0.000233	CcSEcCtD
Dantrolene—Fatigue—Topiramate—epilepsy syndrome	2.63e-05	0.000231	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	2.62e-05	0.000457	CbGpPWpGaD
Dantrolene—Dizziness—Pregabalin—epilepsy syndrome	2.62e-05	0.00023	CcSEcCtD
Dantrolene—Pain—Topiramate—epilepsy syndrome	2.61e-05	0.000229	CcSEcCtD
Dantrolene—Constipation—Topiramate—epilepsy syndrome	2.61e-05	0.000229	CcSEcCtD
Dantrolene—Asthenia—Gabapentin—epilepsy syndrome	2.6e-05	0.000228	CcSEcCtD
Dantrolene—Nausea—Valproic Acid—epilepsy syndrome	2.6e-05	0.000228	CcSEcCtD
Dantrolene—Pruritus—Gabapentin—epilepsy syndrome	2.57e-05	0.000225	CcSEcCtD
Dantrolene—Vomiting—Pregabalin—epilepsy syndrome	2.51e-05	0.000221	CcSEcCtD
Dantrolene—Feeling abnormal—Topiramate—epilepsy syndrome	2.51e-05	0.000221	CcSEcCtD
Dantrolene—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.5e-05	0.000219	CcSEcCtD
Dantrolene—Rash—Pregabalin—epilepsy syndrome	2.49e-05	0.000219	CcSEcCtD
Dantrolene—Dermatitis—Pregabalin—epilepsy syndrome	2.49e-05	0.000219	CcSEcCtD
Dantrolene—Diarrhoea—Gabapentin—epilepsy syndrome	2.48e-05	0.000218	CcSEcCtD
Dantrolene—Headache—Pregabalin—epilepsy syndrome	2.48e-05	0.000218	CcSEcCtD
Dantrolene—Urticaria—Topiramate—epilepsy syndrome	2.42e-05	0.000213	CcSEcCtD
Dantrolene—Abdominal pain—Topiramate—epilepsy syndrome	2.41e-05	0.000212	CcSEcCtD
Dantrolene—Body temperature increased—Topiramate—epilepsy syndrome	2.41e-05	0.000212	CcSEcCtD
Dantrolene—Dizziness—Gabapentin—epilepsy syndrome	2.4e-05	0.000211	CcSEcCtD
Dantrolene—Nausea—Pregabalin—epilepsy syndrome	2.35e-05	0.000206	CcSEcCtD
Dantrolene—Vomiting—Gabapentin—epilepsy syndrome	2.31e-05	0.000202	CcSEcCtD
Dantrolene—Rash—Gabapentin—epilepsy syndrome	2.29e-05	0.000201	CcSEcCtD
Dantrolene—Dermatitis—Gabapentin—epilepsy syndrome	2.28e-05	0.000201	CcSEcCtD
Dantrolene—Headache—Gabapentin—epilepsy syndrome	2.27e-05	0.000199	CcSEcCtD
Dantrolene—Hypersensitivity—Topiramate—epilepsy syndrome	2.25e-05	0.000197	CcSEcCtD
Dantrolene—Asthenia—Topiramate—epilepsy syndrome	2.19e-05	0.000192	CcSEcCtD
Dantrolene—Pruritus—Topiramate—epilepsy syndrome	2.16e-05	0.00019	CcSEcCtD
Dantrolene—Nausea—Gabapentin—epilepsy syndrome	2.15e-05	0.000189	CcSEcCtD
Dantrolene—Diarrhoea—Topiramate—epilepsy syndrome	2.09e-05	0.000183	CcSEcCtD
Dantrolene—Dizziness—Topiramate—epilepsy syndrome	2.02e-05	0.000177	CcSEcCtD
Dantrolene—Vomiting—Topiramate—epilepsy syndrome	1.94e-05	0.00017	CcSEcCtD
Dantrolene—Rash—Topiramate—epilepsy syndrome	1.92e-05	0.000169	CcSEcCtD
Dantrolene—Dermatitis—Topiramate—epilepsy syndrome	1.92e-05	0.000169	CcSEcCtD
Dantrolene—Headache—Topiramate—epilepsy syndrome	1.91e-05	0.000168	CcSEcCtD
Dantrolene—Nausea—Topiramate—epilepsy syndrome	1.81e-05	0.000159	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.58e-05	0.000276	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.55e-05	0.00027	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.54e-05	0.000269	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.53e-05	0.000267	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.52e-05	0.000265	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.39e-05	0.000242	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.37e-05	0.000239	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.28e-05	0.000224	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.06e-05	0.000185	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.03e-06	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.03e-06	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.03e-06	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.03e-06	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.03e-06	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.03e-06	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.35e-06	0.000128	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.35e-06	0.000128	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.35e-06	0.000128	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.35e-06	0.000128	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.83e-06	0.000119	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.83e-06	0.000119	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.81e-06	0.000119	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.42e-06	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.09e-06	0.000106	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.09e-06	0.000106	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.09e-06	0.000106	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.09e-06	0.000106	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.09e-06	0.000106	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.57e-06	9.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.57e-06	9.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.57e-06	9.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.36e-06	9.35e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.18e-06	9.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.18e-06	9.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.87e-06	8.49e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.74e-06	8.26e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.61e-06	8.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.61e-06	8.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.4e-06	7.68e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.4e-06	7.68e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.31e-06	7.52e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.22e-06	7.36e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.14e-06	7.22e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.06e-06	7.09e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.8e-06	6.63e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.69e-06	6.44e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.34e-06	5.82e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.34e-06	5.82e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.72e-06	4.74e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.65e-06	4.62e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.63e-06	4.59e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.38e-06	4.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.26e-06	3.95e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.25e-06	3.93e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.15e-06	3.75e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.13e-06	3.71e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TH—epilepsy syndrome	2.12e-06	3.7e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.77e-06	3.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.74e-06	3.04e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.7e-06	2.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.58e-06	2.75e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.38e-06	2.41e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.36e-06	2.37e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.16e-06	2.03e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.06e-06	1.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.29e-07	1.62e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.67e-07	8.14e-06	CbGpPWpGaD
